https://cd3.be/portfolio/adpkd-inhibitors/ 2026-08-19T13:20:42+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/05/Osp-San-Raph-2.png https://cd3.be/portfolio/yap-taz-inhibitors/ 2026-08-19T14:06:20+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/04/CD3-partner-VIB.png https://cd3.be/portfolio/alpha-syn-inhibitors/ 2026-09-04T14:44:19+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/portfolio/rsv-inhibitors/ 2026-09-04T14:45:43+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/portfolio/rna-polymerase/ 2026-09-04T14:46:28+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/portfolio/ntm-inhibitors/ 2026-09-10T16:02:38+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/portfolio/hrv-inhibitors/ 2026-09-11T09:03:58+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/portfolio/cgas-peripheral-program/ 2026-09-15T11:25:30+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/04/CD3-partner-IOCB.png https://cd3.be/portfolio/cgas-cns-program/ 2026-09-15T11:26:23+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/04/CD3-partner-IOCB.png https://cd3.be/portfolio/ntcp-inhibitors/ 2026-09-15T11:27:10+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/05/UMC-amsterdam-scaled.png https://cd3.be/portfolio/sars-cov-2-inhibitors/ 2026-09-15T11:28:16+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/portfolio/pandemic-epidemic-preparedness/ 2026-09-15T11:29:02+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png https://cd3.be/cdthree/wp-content/uploads/2026/04/virusbank.png https://cd3.be/portfolio/hcm-inhibitors/ 2026-09-15T11:29:37+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/05/UMC-amsterdam-scaled.png https://cd3.be/portfolio/pioneering-trpm3-inhibitors-for-non-opioid-pain-relief/ 2026-09-18T12:52:37+00:00 http://cd3.be/cdthree/wp-content/uploads/2026/03/CD3-succes_stories-pain_relief.jpg https://cd3.be/cdthree/wp-content/uploads/2026/03/CD3-icon-green.png https://cd3.be/portfolio/from-hippo-mutant-flies-to-yap-tead-inhibitors-for-hard-to-treat-cancers/ 2026-09-18T12:55:57+00:00 http://cd3.be/cdthree/wp-content/uploads/2026/03/CD3-succes_stories-TEAD.jpg https://cd3.be/cdthree/wp-content/uploads/2026/03/CD3-icon-green.png https://cd3.be/portfolio/from-academic-insight-to-phase-ii-birth-of-a-first-in-class-dengue-antiviral-program/ 2026-10-16T12:12:49+00:00 http://cd3.be/cdthree/wp-content/uploads/2026/03/CD3-succes_stories-dengue.jpg https://cd3.be/cdthree/wp-content/uploads/2026/03/CD3-icon-green.png https://cd3.be/portfolio/dengue-virus-inhibitors/ 2026-10-16T12:20:49+00:00 https://cd3.be/cdthree/wp-content/uploads/2026/08/KU-Leuven-logo.png